Abstract: A measurement device includes a measurement head configured to capture dimensional measurement data of a measurement object. A guide structure is configured to move and guide at least one of the measurement head and the measurement object in a measurement volume of the measurement device. A measurement unit is configured to capture positional data of the guide structure based on which a pose of the measurement head can be calculated. Multiple temperature sensor units are configured to capture temperature data about the measurement volume. Each temperature sensor unit includes a carrier element, a temperature sensor connected to the carrier element, and a heating element connected to the carrier element. A control system is configured to process the dimensional measurement data and the positional data and, based on the temperature data, correct at least one of the dimensional measurement data and the positional data.

Abstract: The present invention relates to a bispecific antibody construct comprising a first human binding domain which binds to human CDH3 on the surface of a target cell and a second binding domain which binds to human CDS on the surface of a T cell. Moreover, the invention provides a polynucleotide encoding the antibody construct, a vector comprising said polynucleotide and a host cell transformed or transected with said polynucleotide or vector. Furthermore, the invention provides a process for the production of the antibody construct of the invention, a medical use of said antibody construct and a kit comprising said antibody construct.

Abstract: The present invention relates to uses of bispecific antibodies exhibiting cross-species specificity for evaluating the in vivo safety and/or activity and/or pharmacokinetic profile of the same in non-human species and humans. The present invention moreover relates to methods for evaluating the in vivo safety and/or activity and/or pharmacokinetic profile of said bispecific antibodies exhibiting cross-species specificity. The present invention also relates to methods of measuring the biological activity and/or efficacy of such bispecific antibodies exhibiting cross-species specificity. In addition, the present invention relates to pharmaceutical compositions comprising bispecific single chain antibodies exhibiting cross-species specificity and to methods for the preparation of pharmaceutical compositions comprising said bispecific single chain antibodies exhibiting cross-species specificity for the treatment of diseases.

Abstract: An oil separator separates oil from aerosol in a combustion engine. The oil separator includes a housing having an inlet opening for the aerosol, an impeller which can be rotatably driven about a rotational axis, and which is adapted for generating an aerosol flow along an axial direction of the impeller and arranged in the housing, and an impact wall which is designed in such a way that a projection of the impeller oriented axially and downstream in the air flow impinges on the impact wall. At least one part of a projection of the impeller oriented axially and downstream in the air flow impinges on the inlet opening.

Abstract: An oil separator separates oil from aerosol in a combustion engine. The oil separator includes a housing having an inlet opening for the aerosol, an impeller which can be rotatably driven about a rotational axis, and which is adapted for generating an aerosol flow along an axial direction of the impeller and arranged in the housing, and an impact wall which is designed in such a way that a projection of the impeller oriented axially and downstream in the air flow impinges on the impact wall. At least one part of a projection of the impeller oriented axially and downstream in the air flow impinges on the inlet opening.

Abstract: Therapeutic system with implantable therapeutic unit (ITU) comprising control unit (CU), memory, telemetry unit connected (in)directly to CU for wireless bidirectional transmission of data to/from external device (ED) and detection unit for detecting physiological patient data or operational data. CU triggers outgoing data transmission (DT) from ITU to ED based on preselected internal events and establishes standby mode for reception on part of telemetry unit for receiving beginning (header) of incoming DT from ED to therapeutic unit exclusively within preselected response time window after DT from ITU to ED.

Abstract: The invention relates to a method for producing alkenyl succinic anhydrides of formula (1), in which R represents a C4 to C250 alkylene radical that can be linear or branched. The method involves the reaction of maleic acid, maleic anhydride, fumaric acid or esters thereof and an alkene which contains 4-250 carbon atoms at from 150 to 250° C. in the presence of a synergistic mixture of a primary antioxidant, a secondary antioxidant, and a metal deactivator.

Abstract: This invention relates to the use of a compound of the formula (I) where R1 is a hydrocarbon group having 1-40 carbon atoms, R2 is an aliphatic hydrocarbon group having 2-4 carbon atoms, and also R3 is an alkoxy group, n is in the range from 1 to 50, and m is 1 or 2, as flotation reagent in silicate flotation R1—O—R2—NH(2-m)—[(R3)n—H]m??(I).

Abstract: The invention relates to the use of a compound of formula R—N-[A-NH2]2??(1) wherein R represents a linear or branched alkyl group or alkenyl group having 6 to 20 carbon atoms while A represents a C2 to C4 alkylene group, as collector in silicate flotation.

Abstract: The present invention relates a flotation reagent for sulfidic ores, containing at least one compound of formula (1), wherein R2, R3, R4, R5, R6 and R7, independent of one another, represent hydrogen or groups containing 1 to 15 carbon atoms or groups containing oxygen or nitrogen, and at least another compound serving as collector and containing at least one sulfur atom that is directly bound to a carbon or phosphorus atom, wherein the carbon or phosphorus atom is directly bound to at least another sulfur atom or an oxygen atom.

Abstract: A method for the flotation of sulfide ores is disclosed. The method comprises contacting the sulfide ores with a composition comprising at least one compound of the formula where R1, R2 and R3 independently of one another are alkyl groups having 1 to 18 carbon atoms, alkenyl groups having 2 to 18 carbon atoms, aryl groups having 6 to 10 carbon atoms, or alkylaryl groups having 7 to 10 carbon atoms. Also disclosed is the process for preparing the above compound.

Abstract: The invention relates to the use of a compound of formula R—N-[A-NH2]2??(1) wherein R represents a linear or branched alkyl group or alkenyl group having 6 to 20 carbon atoms while A represents a C2 to C4 alkylene group, as collector in silicate flotation.

Abstract: This invention relates to the use of a compound of the formula (I) where R1 is a hydrocarbon group having 1-40 carbon atoms, R2 is an aliphatic hydrocarbon group having 2-4 carbon atoms, and also R3 is an alkoxy group, n is in the range from 1 to 50, and m is 1 or 2, as flotation reagent in silicate flotation R1—O—R2—NH(2-m)—[(R3)n—H]m??(I)

Abstract: Therapeutic system with implantable therapeutic unit (ITU) comprising control unit (CU), memory, telemetry unit connected (in)directly to CU for wireless bidirectional transmission of data to/from external device (ED) and detection unit for detecting physiological patient data or operational data. CU triggers outgoing data transmission (DT) from ITU to ED based on preselected internal events and establishes standby mode for reception on part of telemetry unit for receiving beginning (header) of incoming DT from ED to therapeutic unit exclusively within preselected response time window after DT from ITU to ED.

Abstract: The invention relates to a method for producing alkenyl succinic anhydrides of formula (1), in which R represents a C4 to C250 alkylene radical that can be linear or branched. The method involves the reaction of maleic acid, maleic anhydride, fumaric acid or esters thereof and an alkene which contains 4-250 carbon atoms at from 150 to 250° C. in the presence of a synergistic mixture of a primary antioxidant, a secondary antioxidant, and a metal deactivator.

Abstract: The present invention relates a flotation reagent for sulfidic ores, containing at least one compound of formula (1), wherein R2, R3, R4, R5, R6 and R7, independent of one another, represent hydrogen or groups containing 1 to 15 carbon atoms or groups containing oxygen or nitrogen, and at least another compound serving as collector and containing at least one sulfur atom that is directly bound to a carbon or phosphorus atom, wherein the carbon or phosphorus atom is directly bound to at least another sulfur atom or an oxygen atom.

Abstract: A method for the flotation of sulfide ores is disclosed. The method comprises contacting the sulfide ores with a composition comprising at least one compound of the formula where R1, R2 and R3 independently of one another are alkyl groups having 1 to 18 carbon atoms, alkenyl groups having 2 to 18 carbon atoms, aryl groups having 6 to 10 carbon atoms, or alkylaryl groups having 7 to 10 carbon atoms. Also disclosed is the process for preparing the above compound.

Abstract: A method for the flotation of sulfide ores is disclosed. The method comprises contacting the sulfide ores with a composition comprising at least one compound of the formula where R1, R2 and R3 independently of one another are alkyl groups having 1 to 18 carbon atoms, alkenyl groups having 2 to 18 carbon atoms, aryl groups having 6 to 10 carbon atoms, or alkylaryl groups having 7 to 10 carbon atoms.

Abstract: The invention relates to a composition which is effective as a flotation reagent for collecting and separating potash salt mixtures. The flotation reagent comprises A) at least one compound of the formula [R1—NH3]+X?, where R1 is a C8 to C22 alkyl radical and X? is an anion, and B) a branched fatty acid having a chain length of 8 to 22 carbon atoms.

Abstract: A method for the flotation of sulfide ores is disclosed. The method comprises contacting the sulfide ores with a composition comprising at least one compound of the formula where R1, R2 and R3 independently of one another are alkyl groups having 1 to 18 carbon atoms, alkenyl groups having 2 to 18 carbon atoms, aryl groups having 6 to 10 carbon atoms, or alkylaryl groups having 7 to 10 carbon atoms.